Verastem target price raised to $22 from $18 by Alliance Global Partners
VSTM•Alliance Global Partners raised its target price for Verastem to $22 from $18.
Related News
Mondelēz International publishes update to financial calendar
MDLZ•
ECARX says ending US$100 million convertible note option limits further shareholder dilution
ECX•
Evolution Metals & Technologies reaffirms fiscal 2027 revenue guidance of $400 million to $460 million
EMAT•
CytoDyn to host investor webcast on corporate and clinical progress
CYDY•
Aquestive Therapeutics announces FDA acceptance of Anaphylm NDA resubmission and March 16, 2027 PDUFA goal date
AQST•